Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Pregnancy Complications »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pregnancy < Pregnancy Complications < Pregnancy Complications, Cardiovascular  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000292 (2019) Jumpei Saito ; Naho Yakuwa ; Kayoko Kaneko [Japon] ; Chinatsu Takai ; Mikako Goto ; Ken Nakajima ; Akimasa Yamatani ; Atsuko MurashimaTocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum.
000391 (2019) Yoshifumi Tada [Japon] ; Mariko Sakai [Japon] ; Yoshinobu Nakao [Japon] ; Akihito Maruyama [Japon] ; Nobuyuki Ono [Japon] ; Syuichi Koarada [Japon]Placental transfer of tocilizumab in a patient with rheumatoid arthritis.
000653 (2018) Jumpei Saito [Japon] ; Naho Yakuwa [Japon] ; Chinatsu Takai [Japon] ; Ken Nakajima [Japon] ; Kayoko Kaneko [Japon] ; Mikako Goto [Japon] ; Yoichi Ishikawa [Japon] ; Atsuko Murashima [Japon]Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study.
000661 (2018) Maria Gerosa [Italie] ; Lorenza Maria Argolini [Italie] ; Carolina Artusi [Italie] ; Cecilia Beatrice Chighizola [Italie]The use of biologics and small molecules in pregnant patients with rheumatic diseases.
000A19 (2017) Monika Stensen [Norvège]The use of biologics in pregnant patients with rheumatic disease.
000C55 (2016) Jaume Alijotas-Reig [Espagne] ; Enrique Esteve-Valverde [Espagne] ; Raquel Ferrer-Oliveras [Espagne][Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease].
000C81 (2016) Frauke Förger [Suisse] ; Peter M. Villiger [Suisse]Treatment of rheumatoid arthritis during pregnancy: present and future.
000D23 (2016) Carina Götestam Skorpen [Norvège] ; Maria Hoeltzenbein [Allemagne] ; Angela Tincani [Italie] ; Rebecca Fischer-Betz [Allemagne] ; Elisabeth Elefant [France] ; Christina Chambers [États-Unis] ; Josè Da Silva [Portugal] ; Catherine Nelson-Piercy [Royaume-Uni] ; Irene Cetin [Italie] ; Nathalie Costedoat-Chalumeau [France] ; Radboud Dolhain [Pays-Bas] ; Frauke Förger [Suisse] ; Munther Khamashta [Royaume-Uni] ; Guillermo Ruiz-Irastorza [Espagne] ; Angela Zink [Allemagne] ; Jiri Vencovsky [République tchèque] ; Maurizio Cutolo [Italie] ; Nele Caeyers [Belgique] ; Claudia Zumbühl [Suisse] ; Monika Stensen [Norvège]The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
000E86 (2016) Roger A. Levy [Brésil] ; Guilherme R. De Jesús [Brésil] ; Nilson R. De Jesús [Brésil] ; Evandro M. Klumb [Brésil]Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation.
000F08 (2016) Maria Gerosa [Italie] ; Tommaso Schioppo [Italie] ; Pier Luigi Meroni [Italie]Challenges and treatment options for rheumatoid arthritis during pregnancy.
001191 (2015) A. Calligaro [Oman] ; A. Hoxha ; A. Ruffatti ; L. PunziAre biological drugs safe in pregnancy?
001292 (2014) Monika Ostensen [Norvège]Safety issues of biologics in pregnant patients with rheumatic diseases.
001644 (2012) O. Psenak [Autriche] ; A. Studnicka-Benke ; R. Greil[Safety of immunosuppressants].
001824 (2011) Monika Ostensen [Suisse] ; Frauke FörgerTreatment with biologics of pregnant patients with rheumatic diseases.
001862 (2011) Ashima Makol [États-Unis] ; Kerry Wright ; Shreyasee AminRheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
001D37 (????) Chiara Bazzani [Italie] ; Rossana Scrivo [Italie] ; Laura Andreoli [Italie] ; Elena Baldissera [Italie] ; Martina Biggioggero [Italie] ; Valentina Canti [Italie] ; Maria Gerosa [Italie] ; Irene Pontikaki [Italie] ; Véronique Ramoni [Italie] ; Laura Trespidi [Italie] ; Sonia Zatti [Italie] ; Roberto Caporali [Italie] ; Roberto Gorla [Italie] ; Florenzo Iannone [Italie] ; Andrea Lojacono [Italie] ; Pierluigi Meroni [Italie] ; Carlomaurizio Montecucco [Italie] ; Mario Motta [Italie] ; Maria Grazia Sabbadini [Italie] ; Guido Valesini [Italie] ; Angela Tincani [Italie]Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Pregnancy Complications" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Pregnancy Complications" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Pregnancy Complications
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021